In order to address data collection and study design needs throughout the RPCI catchment area and beyond, the Survey Research and Data Acquisition Resource (SRDAR) provides access to large population-based data in the primary service area and in other areas as scientific needs may dictate. Specific SRDAR services include telephone, in-person, electronic, and forms-based surveying;survey and study design and development;measure validation;investigator and staff training;project development and consultation;and national multi-center project collaboration and conduct. This Resource provides broad-based expertise to facilitate transdisciplinary research among population science and clinical investigators. Having this in-house capability allows for centralized data collection with built-in checks and balances of study logistics, at a significant cost savings over using external service providers. SRDAR has experience with multi-Center and multi-organizational projects at the national and international levels. SRDAR fosters collaboration across other NCI and peer-reviewed mechanisms, including program projects, SPOREs, and NCTN clinical research. For example, in one NCI-funded study to increase website traffic to the website offered by the New York State Smoker's Quitline (NYSSQL), SRDAR assisted 560,000 participants in 2012. First priority for use is given to peer-reviewed funded RPCI CCSG members;second priority to non-peer review funded CCSG members;third priority to non-members and academic collaborators;and last priority to external users. During the reporting period, the SRDAR Shared Resource has served 5 members from 2 research programs, with 16% utilization by CCSG members with peer reviewed funding. SRDAR has also assisted other national or collaborative projects including those with the Hollings Cancer Center (3P01GA138389-05S1), University of Michigan Cancer Center (5P50CA101451-10), Yale Cancer Center (R01CA068427-13) and Sidney Kimmel Comprehensive Cancer Center. SRDAR currently has 43 employees including 29 trained data collection staff. The CCSG support provides 3% of the overall proposed budget.
SRDAR serves as a centralized resource at RPCI that specializes in facilitating, collecting, and improving the quality of survey research data from clinical and population-based studies. Having this in-house capability impacts RPCI studies throughout the 8-county catchment area, and enables conduct of large epidemiologic, education, and dissemination studies.
|Mahoney, Martin C; Erwin, Deborah O; Twarozek, Annamaria Masucci et al. (2018) Leveraging technology to promote smoking cessation in urban and rural primary care medical offices. Prev Med 114:102-106|
|Cheng, Ting-Yuan David; Darke, Amy K; Redman, Mary W et al. (2018) Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424). J Natl Cancer Inst 110:734-742|
|Zonneville, Justin; Safina, Alfiya; Truskinovsky, Alexander M et al. (2018) TGF-? signaling promotes tumor vasculature by enhancing the pericyte-endothelium association. BMC Cancer 18:670|
|Rabi, Thangaiyan; Li, Fengzhi (2018) Multiple mechanisms involved in a low concentration of FL118 enhancement of AMR-MeOAc to induce pancreatic cancer cell apoptosis and growth inhibition. Am J Cancer Res 8:2267-2283|
|Haring, Rodney C; Henry, Whitney Ann; Hudson, Maui et al. (2018) Views on clinical trial recruitment, biospecimen collection, and cancer research: population science from landscapes of the Haudenosaunee (People of the Longhouse). J Cancer Educ 33:44-51|
|Elahi, Seerat; Egan, Shawn M; Holling, G Aaron et al. (2018) The RNA binding protein Ars2 supports hematopoiesis at multiple levels. Exp Hematol 64:45-58.e9|
|La Shu, Shin; Yang, Yunchen; Allen, Cheryl L et al. (2018) Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep 8:12905|
|Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035|
|Dasgupta, Subhamoy; Rajapakshe, Kimal; Zhu, Bokai et al. (2018) Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 556:249-254|
|Ma, Wen Wee; Xie, Hao; Fetterly, Gerald et al. (2018) A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. Am J Clin Oncol :|
Showing the most recent 10 out of 1555 publications